P

Pathos

AI-powered platform for oncology drug development

Director Clinical Science

Clinical Research OperationsUpdated on Nov 15
Full-timeNew York, NY, USA$200k - $240k /yr

About the Job

Requirements

  • A Doctor of Medicine, Doctor of Philosophy, or Doctor of Pharmacy in a relevant life science discipline is required.
  • At least 5 years of oncology clinical development experience in biotech or pharma, including direct ownership of protocol design and clinical content authoring.
  • A demonstrated track record of delivering study protocols and regulatory documents across Phase 1 and Phase 2 oncology trials.
  • Experience in solid tumor oncology and deep familiarity with Good Clinical Practice and applicable regulatory requirements.
  • Strong scientific writing ability to distill complex evidence into clear, decision-relevant documents.

Responsibilities

  • Author and own study protocols from first draft through amendments, including study design, eligibility criteria, endpoint selection, and safety monitoring plans.
  • Write and maintain Investigator Brochures, informed consent forms, Clinical Study Reports, and briefing documents in partnership with Clinical Operations and Medical Writing.
  • Direct AI agents to compile source data, structure document drafts, and run quality checks, then apply scientific judgment to finalize each deliverable.
  • Conduct ongoing review of safety and efficacy data across active studies, including eligibility confirmation, protocol deviation assessment, and adverse event review.
  • Prepare materials and lead deliverables for data monitoring committees and other clinical review bodies.
  • Collaborate with data management on electronic case report form development, edit check design, and database lock activities.
  • Serve as the scientific point of contact for clinical investigators during study startup, conduct, and closeout.
  • Provide protocol training at investigator meetings, site initiation visits, and internal study team kickoffs.
  • Work with Clinical Operations to identify and resolve site-level issues affecting data quality or enrollment integrity.
  • Prepare scientific content for regulatory authority interactions, including Investigational New Drug amendments, briefing books, and submission dossiers.
  • Support responses to Health Authority questions with accurate, well-reasoned clinical and scientific rationale.
  • Maintain Good Clinical Practice compliance and audit-ready trial conduct across assigned programs.

Desired Qualifications

  • Experience integrating biomarker and translational strategies into trial design, particularly in genomically defined or molecularly enriched patient populations.
  • Comfort working with AI-generated analyses, real-world evidence, and computational predictions as inputs to scientific and clinical decisions.
  • Experience contributing to clinical development plans for multiple concurrent programs in a fast-moving organization.
  • Familiarity with agentic or AI-assisted workflows for document generation, data review, or literature surveillance.
  • Experience designing or contributing to adaptive trial designs or platform trials.
  • Direct engagement with Health Authorities on oncology programs, including Investigational New Drug and FDA briefing meetings.

About the Company

Pathos

AI-powered platform for oncology drug development

Pathos combines artificial intelligence with oncology to speed up cancer drug development. It analyzes large oncology datasets, including genomics, using advanced AI and machine learning to identify novel therapeutic targets and biomarkers, guiding the creation of more effective, personalized cancer treatments. The company collaborates with pharmaceutical and biotechnology partners to de-risk pipelines, shorten development timelines, and increase the odds of success for new cancer therapies. Pathos differentiates itself by offering an integrated data-driven platform that leverages diverse genomic and clinical data to drive target validation and biomarker discovery for partner programs. Its goal is to accelerate the delivery of better cancer treatments by turning complex data into actionable insights.

Company size
51-200
Company stage
Series D
Total funding
$447M
Headquarters
Chicago, IL
Founded
2022

Recently Posted Jobs

Explore more opportunities at Pathos

See more jobs